| 2025/0114,431 | COMPOUND, COMPOSITION AND METHODS FOR LOWERING CIRCULATING GLUCOSE | Oct 10, 23 | Apr 10, 25 | Not available |
| 2025/0114,436 | DYNAMIC-COVALENT HYDROGELS WITH GLUCOSE-SPECIFIC AND GLUCOSE-RESPONSIVE DIBORONATE CROSSLINKING | Feb 08, 23 | Apr 10, 25 | Not available |
| 2025/0115,654 | PHARMACEUTICAL COMPOSITION OF GLP-1 RECEPTOR AND GIP RECEPTOR DUAL AGONIST, AND USE THEREOF | Nov 11, 22 | Apr 10, 25 | Not available |
| 2025/0115,672 | CANINE ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF | Jun 13, 24 | Apr 10, 25 | Not available |
| 2025/0108,032 | METHODS OF TREATING TYPE 1 DIABETES AND KIDNEY DISEASE | Sep 26, 24 | Apr 03, 25 | Lexicon Pharmaceuticals Inc. |
| 2025/0108,065 | METHODS OF TREATING PREDIABETES OR REDUCING THE RISK OF DEVELOPING TYPE 2 DIABETES WITH DAPAGLIFLOZIN | Jan 25, 23 | Apr 03, 25 | Not available |
| 2025/0108,072 | NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAME | Sep 10, 24 | Apr 03, 25 | Not available |
| 2025/0108,078 | MECHANISTIC BACTERIAL EFECTOR TO PREVENT APOPTOSIS OF HUMAN BETA CELLS | Dec 12, 24 | Apr 03, 25 | Not available |
| 2025/0108,089 | METHODS AND COMPOSITIONS FOR TREATING DIABETES, AND METHODS FOR ENRICHING MRNA CODING FOR SECRETED PROTEINS | Sep 18, 24 | Apr 03, 25 | Not available |
| 2025/0109,168 | POLYPEPTIDE AND USE THEREOF IN REGULATING BLOOD GLUCOSE LEVEL AND/OR REDUCING FAT | Sep 24, 24 | Apr 03, 25 | Not available |
| 2025/0099,411 | Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators | Apr 24, 24 | Mar 27, 25 | Institut Pasteur de Montevideo; Universidad de la República; |
| 2025/0099,562 | IMMUNOSUPPRESSIVE ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR TREG CELLS FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS | Dec 06, 24 | Mar 27, 25 | The University of Toledo |
| 2025/0090,529 | USE OF SHP2 INHIBITORS FOR THE TREATMENT OF INSULIN RESISTANCE | Aug 20, 24 | Mar 20, 25 | Not available |
| 2025/0090,595 | THERAPEUTIC USE OF CANCER-ASSOCIATED FIBROBLAST-ENCAPSULATED PANCREATIC BETA CELLS FOR TREATING DIABETES | Sep 13, 24 | Mar 20, 25 | Not available |
| 2025/0090,596 | MODULATING INFLAMMATION ASSOCIATED WITH FOREIGN BODY RESPONSE | Sep 14, 24 | Mar 20, 25 | Not available |
| 2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
| 2025/0082,731 | TRANSDERMAL INSULIN FORMULATIONS AND METHODS OF USE THEREOF | Sep 08, 22 | Mar 13, 25 | Transdermal Delivery Solutions Corp. (d.b.a. HypoSpray Pharma) |
| 2025/0082,781 | METHODS OF LOWERING BLOOD GLUCOSE AND TREATING TYPE 2 DIABETES BY ACTIVATION OF PDE4D3 | Dec 28, 22 | Mar 13, 25 | Salk Institute for Biological Studies |
| 2025/0082,642 | TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG | Nov 27, 24 | Mar 13, 25 | Not available |
| 2025/0073,283 | STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE | Oct 06, 21 | Mar 06, 25 | Not available |